The Royal Australian and New Zealand College of Radiologists Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00123318
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Skin Neoplasms (Phase 3)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4